Journal of Diabetes Research / 2012 / Article / Tab 1

Research Article

Angiotensin-Converting Enzyme Genotype and Peripheral Arterial Disease in Diabetic Patients

Table 1

Comparisons of characteristics of study subjects with and without peripheral arterial disease.

CharacteristicsPeripheral arterial disease  
YesNo

81864
Age, years72.9 (7.3)62.6 (11.3)<0.001
Sex
  Men31 (38.3)423 (49.0)0.066
 Women50 (61.7)441 (51.0)
Duration of diabetes, years16.3 (9.3)10.8 (7.7)<0.001
Body mass index, kg/m223.6 (3.3)24.9 (3.4)0.001
Smoking
  Never smokers51 (63.0)560 (64.9)>0.1
 Current or former smokers30 (37.0)303 (35.1)
Hypertension
 No17 (21.0)369 (42.7)<0.001
 Yes64 (79.0)495 (57.3)
Systolic blood pressure, mmHg146.0 (18.2)134.0 (17.3)<0.001
Diastolic blood pressure, mmHg82.9 (12.0)83.4 (9.6)>0.1
Hemoglobin , %7.9 (1.6)7.9 (1.9)>0.1
Dyslipidemia
 No18 (22.2)316 (36.6)0.010
 Yes63 (77.8)548 (63.4)
Total cholesterol, mg/dL209.7 (42.2)205.1 (43.3)>0.1
Ln(triglycerides), mg/dL5.1 (0.6)5.0 (0.6)0.03
High-density lipoprotein cholesterol, mg/dL46.8 (12.7)48.1 (13.6)>0.1
Low-density lipoprotein cholesterol, mg/dL115.5 (34.9)114.2 (33.8)>0.1
Ln[lipoprotein (a)], mg/dL5.0 (1.2)4.7 (1.1)0.011
Uric acid, mg/dL5.9 (2.2)5.2 (2.0)0.006
Angiotensin-converting enzyme genotype
  II35 (43.2)430 (49.8)>0.1
 ID34 (42.0)358 (41.4)
 DD12 (14.8)76 (8.8)
Allele frequency
 I104 (64.2)1,218 (70.5)>0.1
 D58 (35.8)510 (29.5)

Data are expressed as mean (SD) or (percentage).

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.